Key Market Indicator:
In the Research & Ratings section, you can access assessments from renowned analyst firms that specialize in the due diligence and valuation of companies that are generally listed on the stock exchange. Starting from the research reports, you can access further research tools and information with just a few mouse clicks, which offer you additional options for obtaining and assessing information.
DE000A0MSN11
Mon, 15.04.2024
Nynomic AG
New product launched: Another building block for the mid-term
Nynomic announced that its subsidiary Spectral Engines and Kraemer
Elektronik, an expert for high quality testing systems of bulk solids for
the pharmaceutical, chemical and food industry, have jointly developed and
now presented a new product, the LabScanner Plus.
While Kraemer El [ … ]
Wed, 21.02.2024
Nynomic AG
Strong Q4 expected // 2024 to be marked by significant growth
Topic: Nynomic should report strong Q4 prelims. More importantly, FY24e
should be marked by strong sales growth and further margin improvements as
well as additional (potentially larger) acquisitions.
Q4 sales are seen to come in at € 37.6m (+14% yoy; FY23e sales +4% yoy)
than [ … ]
Mon, 18.12.2023
Nynomic AG
Bolt-on acquisition with high synergy potential; chg.
Topic: Nynomic announced the 100% acquisition of art photonic (13th pillar
of the Nynomic group), which should be highly value accretive during the
coming years thanks to significant synergy potential.
In detail, art photonic is a Berlin-based expert in the development and
production of hi [ … ]
Fri, 10.11.2023
Nynomic AG
Solid Q3 prelims with disproportionally stronger Q4 expected
Preliminary Q3 sales came in at € 30.6m (eNuW: € 34.2m), a 3.4% yoy
increase (-2% qoq). The slow growth can be explained by several larger
projects/orders whose delivery/call-off had been scheduled for Q4 or has
even been pushed into 2024. While customers are generally more [ … ]